OKYO Pharma Limited
Martello Court
Admiral Park
St. Peter Port
Guernsey GY1 3HB
| June 12, 2023 |
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Daniel Crawford
| Re: | OKYO Pharma Limited | |
| Registration Statement on Form F-3 | ||
| June 8, 2023 | ||
| File No. 333-272516 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, OKYO Pharma Limited (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Daylight Time, on Wednesday, June 14, 2023, or as soon thereafter as possible.
Please notify Jeff Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
| OKYO Pharma Limited | ||
| By: | /s/ Gary Jacob | |
| Name: | Gary Jacob | |
| Title: | Chief Executive Officer | |
| -1- |
